Company Active LTD

Company profile

Clin-E-Cal LTD.

Clin-e-cal

Clin-E-Cal LTD. is a UK company with status active founded in 2014 based in North West England.

CRN
09346983
Founded
2014
Age
11

Overview

Legal name
CLIN-E-CAL LTD.
Region
North West England
Registered address
103 GRAVEL LANE
WILMSLOW
UNITED KINGDOM
SK9 6LZ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

11 levels 2 ultimate controllers
1
Company Active LTD
Clin-E-Cal LTD.
CRN 09346983
2
Direct controller Active LLP
3
Intermediate controller Active LTD
4
Intermediate controller Active LTD
5
Intermediate controller Active LTD
6
Ultimate controller Active LTD
7
Intermediate controller Active LLP
Barnett Waddingham LLP
CRN OC307678
8
Intermediate controller Active LTD
9
Intermediate controller Active LTD
10
Intermediate controller Active LTD
11
Intermediate controller Active LTD
HGH Midco 3 Limited
CRN 13646017
12
Intermediate controller Active LTD
Hig Finance 2 Limited
CRN 10842605
13
Intermediate controller Active LTD
HGH Finance Limited
CRN 13645436
14
Intermediate controller Active LTD
HGH Midco 2 Limited
CRN 13644440
15
Intermediate controller Active LTD
HGH Midco 1 Limited
CRN 13642978
16
Ultimate controller Active LTD

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1

Company events

Reference milestones and recent Companies House filing stream events.

5 events
20 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

06 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

09 Dec
2014

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2015
Funded years
2015, 2019
Age at first award
0 years

Projects

2019 Collaborative R&D Lead participant

Development of a non-bluetooth smart inhaler.

1 Feb 2019 to 31 Jan 2020

Awarded
£133,925
Total cost £297,610

People with respiratory diseases, including asthma and COPD are usually treated with inhaler medication. This medication is designed for two purposes - preventing the disease symptoms day to day and treating incidences of worsening symptoms known as exacerbations. If a patient fails to take the preventer inhaler regularly or it is taken incorrectly, this ...

2015 SME Support Lead participant

Clin-e-cal Ltd(add onto 700565)

1 Dec 2015 to 29 Feb 2016

Awarded
£600
Total cost £600

Awaiting Public Project Summary

2015 GRD Proof of Market Lead participant

Rafi-tone: Market testing resubmission

1 Jul 2015 to 31 Dec 2015

Awarded
£24,930
Total cost £41,550

Viral induced wheeze or chronic wheeze associated with asthma affects 5.5 million children under 5 in Europe and the US. Our company, Clin-e-cal Ltd, has developed Rafi-tone, an innovative device which has been created to aid compliance of young children to inhaler medication delivered via a spacer device. Rafi-tone addresses two problems: in the short te...

Product types

Collaborative R&D GRD Proof of Market SME Support